Diabetology & Metabolic Syndrome
Scope & Guideline
Fostering breakthroughs in metabolic syndrome research.
Introduction
Aims and Scopes
- Diabetes Management and Treatment Strategies:
Research on various treatment modalities for diabetes, including pharmacological interventions (like GLP-1 receptor agonists and SGLT2 inhibitors), dietary approaches, and lifestyle modifications aimed at improving glycemic control and managing diabetes-related complications. - Cardiometabolic Health:
Studies investigating the interrelations between diabetes and cardiovascular diseases, metabolic syndrome, and other comorbidities, focusing on risk factors, outcomes, and management strategies. - Pathophysiology of Diabetes Complications:
Research into the underlying mechanisms of diabetes-related complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease, often utilizing molecular, genetic, and epigenetic analyses. - Innovative Diagnostic and Monitoring Technologies:
Advancements in diabetes monitoring technologies such as continuous glucose monitoring systems, machine learning applications for diabetes risk prediction, and novel biomarkers for early detection of diabetes-related complications. - Public Health and Epidemiology:
Investigations into the prevalence, risk factors, and socio-economic impacts of diabetes and metabolic syndrome at population levels, aiming to inform public health policies and interventions. - Patient-Centered Care and Education:
Research focusing on the psychosocial aspects of diabetes, including patient education, self-management strategies, and the impact of mental health on diabetes outcomes.
Trending and Emerging
- Molecular Mechanisms and Biomarkers:
There is a growing emphasis on understanding the molecular mechanisms underlying diabetes and its complications, including the identification of novel biomarkers for early detection and monitoring of diabetes-related conditions. - Impact of Gut Microbiota:
Research exploring the relationship between gut microbiota and diabetes has gained traction, focusing on how gut health influences metabolic processes, insulin resistance, and overall diabetes management. - Psychosocial and Behavioral Aspects of Diabetes Management:
Increasing attention is being paid to the psychosocial dimensions of diabetes, including the effects of mental health, stress, and social support on diabetes outcomes, as well as the role of patient education and self-management. - Artificial Intelligence and Digital Health Technologies:
The integration of artificial intelligence and digital health technologies in diabetes management is an emerging trend, with studies focusing on predictive modeling, telemedicine, and mobile health applications to enhance patient care. - Diabetes in Special Populations:
Research focusing on diabetes management and outcomes in specific populations, such as children, adolescents, pregnant women, and ethnic minorities, is gaining importance, reflecting the need for tailored approaches in diabetes care.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for diabetes management, such as specific diets or food groups, has seen a decline. This shift is likely due to a growing emphasis on personalized nutrition and the role of overall dietary patterns. - Single-Agent Pharmacotherapy Studies:
The focus on studies investigating single-agent pharmacotherapy for diabetes management has waned. There is now a greater interest in combination therapies and multi-faceted approaches that address the complexity of diabetes. - Basic Science Studies with Limited Clinical Relevance:
While basic science research remains important, studies that do not translate findings into clinical or practical applications are less prevalent. The journal is increasingly prioritizing research that has direct implications for patient care and outcomes. - Generalized Population Studies:
Research that broadly examines diabetes prevalence without nuanced analysis of specific populations or subgroups is decreasing. There is a trend towards more targeted studies that consider ethnic, cultural, and socio-economic factors influencing diabetes.
Similar Journals
Therapeutic Advances in Endocrinology and Metabolism
Pioneering research for a healthier endocrine future.Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.
HORMONE AND METABOLIC RESEARCH
Pioneering Research for Health and Disease InsightsHORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.
DIABETES OBESITY & METABOLISM
Transforming insights into impactful clinical applications.DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.
ENDOCRINE RESEARCH
Pioneering discoveries in endocrine health.ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.
DIABETOLOGIA
Elevating knowledge in diabetes management and treatment.DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.
Endocrinology Diabetes and Metabolism Case Reports
Empowering Research with Open Access DiscoveriesEndocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.
Annals of Pediatric Endocrinology & Metabolism
Driving progress in the understanding of pediatric metabolic diseases.Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.
Diabetes & Metabolic Syndrome-Clinical Research & Reviews
Connecting Science and Patient CareDiabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Elevating standards in metabolic disorder management.REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.
BMC Endocrine Disorders
Exploring breakthroughs in endocrine health and disorders.BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.